Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020639 (
hypoproteinemia
)
1,134
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Two lines of Japanese quail (AR2.5 and
AR3
) selected for resistance to aflatoxin and a nonselected control line (NS) were fed diets containing 0, 10, and 20 micrograms of aflatoxin/g of feed. Line-related reductions in mortality and growth inhibition clearly demonstrated the resistance of the AR lines to dietary aflatoxin. Two-week cumulative mortality percentages for the NS, AR2.5, and
AR3
lines fed the 10 micrograms/g diet were 13.9, 7.7, and 2.6%, respectively, and 44.4, 17.9, and 12.8% at 20 micrograms/g. Average growth reduction percentages resulting from feeding the 10 and 20 micrograms/g diets to the NS, AR2.5, and
AR3
lines were: 17.3 and 27.5%, 10.7 and 20.1%, and 4.3 and 10.5%, respectively. In addition, AR quail were resistant in varying degrees to the following aflatoxin-induced effects: liver lipid accumulation and enlargement, hepatic protein depletion, elevated hepatic beta-glucuronidase activity, bursal regression, and
hypoproteinemia
. Comparisons of the AR and NS lines fed the control diet revealed no detrimental physiological or biochemical response to selection for aflatoxin resistance. Genetic resistance to aflatoxin was associated with increased relative liver weight, higher liver protein content, and elevated plasma concentrations of protein and lipid compared with NS quail. One or more of these differences may be related to the mechanism of genetic resistance to aflatoxin in AR quail.
...
PMID:Comparative responses of genetically resistant and nonselected Japanese quail to dietary aflatoxin. 399 13